Friends publishes three white papers ahead of annual meeting

<p>The Friends of Cancer Research annual meeting, to be held Nov. 4 in Washington, DC, will focus on three questions facing the field of oncology clinical trial design:&#160; How do clinical researchers create seamless trial designs for drug development in rare cancers? What are the considerations for clinical trial design testing combination drug development?&#160; How [&#8230;]</p> <p>The post <a href="https://cancerletter.com/the-cancer-letter/20251031_3/"…